Koji Yamada Selected Research

Total Parenteral Nutrition

7/2022	The preventive effect of recombinant human hepatocyte growth factor for hepatic steatosis in a rat model of short bowel syndrome.
12/2021	The protective effects of hepatocyte growth factor on the intestinal mucosal atrophy induced by total parenteral nutrition in a rat model.
3/2021	The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model.
12/2018	The effect of intravenous lipid emulsions and mucosal adaptation following massive bowel resection.
12/2016	Ghrelin improves intestinal mucosal atrophy during parenteral nutrition: An experimental study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Yamada Research Topics

Disease

29	Neoplasms (Cancer) 07/2023 - 07/2002
9	Liver Diseases (Liver Disease) 07/2022 - 12/2016
9	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 12/2002
8	Surgical Wound Infection 04/2024 - 12/2011
7	Intestinal Failure 07/2022 - 09/2016
7	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2003
6	Short Bowel Syndrome 07/2022 - 12/2016
5	Infections 01/2023 - 12/2011
5	Neoplasm Metastasis (Metastasis) 09/2021 - 04/2004
4	Pathologic Constriction (Stenosis) 04/2024 - 04/2013
4	Parkinson Disease (Parkinson's Disease) 07/2023 - 11/2013
4	Cognitive Dysfunction 07/2019 - 09/2010
4	Hypersensitivity (Allergy) 01/2004 - 09/2002
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 05/2003
3	Lymphoma (Lymphomas) 10/2021 - 01/2009
3	Melanoma (Melanoma, Malignant) 11/2014 - 06/2010
3	Ischemic Stroke 04/2013 - 09/2007
3	Carcinoma (Carcinomatosis) 02/2013 - 05/2003
3	Carcinogenesis 06/2010 - 03/2002
2	Appendicitis 04/2024 - 10/2022
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2024 - 01/2023
2	Wounds and Injuries (Trauma) 05/2023 - 01/2022
2	Inflammation (Inflammations) 12/2022 - 12/2008
2	Pain (Aches) 10/2022 - 01/2018
2	Choledochal Cyst (Choledochal Cysts) 10/2022 - 01/2022
2	Sepsis (Septicemia) 09/2022 - 09/2016
2	Body Weight (Weight, Body) 12/2021 - 01/2019
2	Atrophy 12/2021 - 12/2016
2	Colonic Neoplasms (Colon Cancer) 04/2020 - 06/2008
2	Amnesia (Dissociative Amnesia) 07/2019 - 12/2018
2	Erectile Dysfunction 09/2013 - 02/2013
2	Stroke (Strokes) 05/2013 - 04/2013
2	Hypertension (High Blood Pressure) 04/2013 - 09/2010
2	Experimental Melanoma 12/2012 - 06/2010
2	Primary Effusion Lymphoma 01/2012 - 12/2011
2	Atopic Dermatitis (Atopic Eczema) 01/2012 - 11/2009
2	Alzheimer Disease (Alzheimer's Disease) 11/2011 - 09/2010
2	Weight Gain 02/2004 - 02/2003
1	Pneumoperitoneum 04/2024

Drug/Important Bio-Agent (IBA)

11	TeaIBA 06/2019 - 01/2004
11	Laminin ReceptorsIBA 11/2014 - 04/2004
8	PolyphenolsIBA 08/2017 - 04/2004
6	Proteins (Proteins, Gene)FDA Link 07/2019 - 07/2009
5	LipidsIBA 02/2021 - 04/2012
4	TocotrienolsIBA 08/2009 - 05/2004
4	Conjugated Linoleic AcidsIBA 07/2005 - 12/2002
4	IgE Receptors (Fc epsilon RI)IBA 01/2004 - 09/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 11/2019
3	Analgesics (Analgesic Drugs)IBA 10/2022 - 01/2018
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 10/2022 - 01/2022
3	EmulsionsIBA 02/2021 - 02/2018
3	Fish OilsIBA 02/2021 - 02/2018
3	Peptides (Polypeptides)IBA 07/2019 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 09/2014 - 02/2012
3	Linoleic Acid (Linoleate)IBA 07/2008 - 07/2003
3	Immunoglobulin E (IgE)IBA 01/2004 - 06/2002
2	istradefyllineIBA 07/2023 - 07/2014
2	C-Reactive ProteinIBA 12/2022 - 04/2013
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2022 - 12/2021
2	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 11/2020
2	Cefazolin (Ancef)FDA LinkGeneric 07/2021 - 12/2011
2	Messenger RNA (mRNA)IBA 08/2019 - 12/2002
2	Monoclonal AntibodiesIBA 08/2019 - 01/2016
2	Scopolamine (Hyoscine)FDA Link 07/2019 - 12/2018
2	Immunoglobulin M (IgM)IBA 01/2019 - 06/2002
2	GhrelinIBA 12/2016 - 12/2016
2	Immunoglobulin G (IgG)IBA 01/2016 - 06/2002
2	SteroidsIBA 01/2016 - 05/2014
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 07/2014 - 11/2013
2	Catechin (Z 7300)IBA 09/2013 - 01/2004
2	Phosphodiesterase 5 InhibitorsIBA 09/2013 - 02/2013
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 09/2013 - 02/2013
2	AcidsIBA 02/2013 - 04/2012
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 02/2013 - 04/2012
2	CaspasesIBA 12/2012 - 01/2008
2	Caspase 8 (Caspase-8)IBA 01/2012 - 09/2009
2	fucoidanIBA 01/2012 - 09/2009
2	Perindopril FDA LinkGeneric 11/2011 - 09/2010
2	imidaprilIBA 11/2011 - 09/2010
2	Enalapril FDA LinkGeneric 11/2011 - 09/2010
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2011 - 09/2010
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 06/2008 - 07/2005
2	Myosin-Light-Chain PhosphataseIBA 06/2008 - 02/2008
2	Dihydrotachysterol (AT 10)IBA 09/2007 - 12/2002
2	Vitamin E FDA LinkGeneric 09/2007 - 05/2004

Therapy/Procedure

6	Parenteral Nutrition 03/2021 - 12/2016
5	Therapeutics 07/2023 - 05/2013
5	Total Parenteral Nutrition 07/2022 - 12/2016
3	Catheters 04/2024 - 09/2016
3	Drug Therapy (Chemotherapy) 10/2021 - 02/2013
3	Oral Administration 07/2014 - 06/2010
2	Laparotomy 07/2023 - 03/2022
2	Gastrostomy 05/2023 - 07/2022
2	Surgical Instruments (Clip) 05/2023 - 11/2013
2	Traction 10/2022 - 07/2022
2	Liver Transplantation 01/2022 - 12/2019
2	Orthopedic Procedures 01/2022 - 10/2020
1	Length of Stay 04/2024
1	Appendectomy 04/2024
1	Operative Time 04/2024